Buda Juice, which makes branded and private label citrus drinks, raised $20 million by offering 2.7 million shares at $7.50, the low end of the range of $7.50 to $9.00.
Buda Juice states that it is pioneering the "UltraFresh" juice category through its end-to-end cold chain platform. Based in Dallas, Texas, its product portfolio consists of fresh citrus juices and wellness shots across multiple brand lines and retail customers, which it believes demonstrates both brand diversification and private label manufacturing capabilities. The company currently operates from its Dallas plant but has plans for facilities in South Carolina (2026) and Arizona/Nevada (2027).
Buda Juice plans to list on the NYSE American under the symbol BUDA. MDB Capital Group acted as sole bookrunner on the deal.
